TREATMENT OF AXIAL SPONDYLOARTHRITIS WITH SECUKINUMAB: A REAL-LIFE RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Smiljanic Tomicevic, L. [1 ]
Padjen, I. [1 ]
Martinic, M. [1 ]
Mayer, M. [1 ]
Anic, B. [1 ]
机构：
[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Med,Dept Internal Med, Div Clin Immunol & Rheumatol, Zagreb, Croatia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD; Spondyloarthritis;
D O I：
10.1136/annrheumdis-2023-eular.6035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0974
引用
收藏
页码：1706 / 1706
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD EXPERIENCE OF SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS IN A PRIVATE HOSPTIAL
    Carneiro, Carlos
    Fernandes, Nuno
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 1 - 1
  • [42] Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
    Ribero, S.
    Ramondetta, A.
    Fabbrocini, G.
    Bettoli, V.
    Potenza, C.
    Chiricozzi, A.
    Licciardello, M.
    Marzano, A. V.
    Bianchi, L.
    Rozzo, G.
    Fania, L.
    Marasca, C.
    Odorici, G.
    Mambrin, A.
    Moltrasio, C.
    Caposiena Caro, R. D.
    Skroza, N.
    Quaglino, P.
    Siliquini, N.
    Dapavo, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E441 - E442
  • [43] Why the Real-Life Diagnosis of Non-Radiographic Axial Spondyloarthritis Is So Difficult
    Slobodin, Gleb
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (06): : 390 - 392
  • [44] LOW DISEASE ACTIVITY IN REAL-LIFE PATIENTS WITH A DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS: AN ACHIEVABLE TARGET?
    Ortolan, A.
    di Murro, S.
    Tur, C.
    Boni, V
    Rubortone, P.
    Capacci, A.
    Calabrese, G.
    Natalello, G.
    De Lorenzis, E.
    Peluso, G.
    D'Agostino, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 17 - 17
  • [45] Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Ambarus, Carmen A.
    Tak, Paul P.
    Baeten, Dominique
    RHEUMATOLOGY, 2013, 52 (10) : 1873 - 1878
  • [46] Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study
    Zhao, Yan
    Cai, Lin
    Liu, Xiao-Yang
    Zhang, Heng
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1324 - 1328
  • [47] Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    Manara, Maria
    D'Angelo, Salvatore
    Ramonda, Roberta
    Punzi, Leonardo
    Addimanda, Olga
    Salvarani, Carlo
    Marchesoni, Antonio
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 301 - 310
  • [48] Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study
    Ennio Lubrano
    Fabio Massimo Perrotta
    Maria Manara
    Salvatore D’Angelo
    Roberta Ramonda
    Leonardo Punzi
    Olga Addimanda
    Carlo Salvarani
    Antonio Marchesoni
    Rheumatology and Therapy, 2020, 7 : 301 - 310
  • [49] Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis
    Avallone, G.
    Cariti, C.
    Dapavo, P.
    Ortoncelli, M.
    Conforto, L.
    Mastorino, L.
    Roccuzzo, G.
    Cavallo, F.
    Rubatto, M.
    Quaglino, P.
    Ribero, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : E574 - E576
  • [50] British Axial Spondyloarthritis Inception Cohort (BAxSIC): a protocol for a multicentre real-world observational cohort study of early axial spondyloarthritis
    Weddell, Jake
    Harrison, Stephanie R.
    Bennett, Alexander N.
    Gaffney, Karl
    Jones, Gareth T.
    Machado, Pedro M.
    Packham, Jonathan
    Sengupta, Raj
    Zhao, Sizheng Steven
    Siebert, Stefan
    Marzo-Ortega, Helena
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (03)
12345